Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm Metastasis / Bone and Bones”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00265200
What this trial is testing

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell LungMetastases
University of Louisville 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857
What this trial is testing

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Who this might be right for
Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more
RayzeBio, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT03796767
What this trial is testing

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+3 more
University of Utah 20
Testing effectiveness (Phase 2)Ended earlyNCT01703065
What this trial is testing

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more
University of Washington 9
Not applicableStudy completedNCT00899665
What this trial is testing

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Who this might be right for
AnemiaMetastatic CancerMyelodysplastic Syndromes+2 more
Barbara Ann Karmanos Cancer Institute 31
Not applicableLooking for participantsNCT03784651
What this trial is testing

Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer

Who this might be right for
Bone FractureGlucose, High BloodInsulin Resistance+2 more
Rigshospitalet, Denmark 120
Not applicableUnknownNCT03908853
What this trial is testing

Pain Phenotyping of Patients With Bone Cancer Pain

Who this might be right for
PainBone MetastasesMetastatic Breast Cancer
University of Copenhagen 70
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01144481
What this trial is testing

Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases

Who this might be right for
Bone MetastasesBreast Cancer
University Health Network, Toronto 60
Testing effectiveness (Phase 2)Study completedNCT00534430
What this trial is testing

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 30
Not applicableStudy completedNCT01374672
What this trial is testing

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaOsteoblastic Osteosarcoma+1 more
Children's Oncology Group 20
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Large-scale testing (Phase 3)Study completedNCT02561039
What this trial is testing

Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 97
Early research (Phase 1)Ended earlyNCT06008483
What this trial is testing

A Dose Finding Study to Treat Bone Tumor(s)

Who this might be right for
Bone CancerBone TumorSolid Tumor+2 more
QSAM Therapeutics, Inc. 5
Post-approval studies (Phase 4)Study completedNCT00099541
What this trial is testing

Non-small Cell Lung Cancer Registry

Who this might be right for
Non-Small-Cell Lung CancerPleural Effusion, Malignant
Novartis Pharmaceuticals 300
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Not applicableLooking for participantsNCT06785077
What this trial is testing

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Who this might be right for
Leukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer
European Institute of Oncology 157
Testing effectiveness (Phase 2)Looking for participantsNCT06538896
What this trial is testing

Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study

Who this might be right for
Triple-negative Breast CancerBone Metastases
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Next Page